Sec Form 4 Filing - Buchholz Richard @ Inspire Medical Systems, Inc. - 2019-09-30

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Buchholz Richard 2. Issuer Name and Ticker or Trading Symbol Inspire Medical Systems, Inc. [ INSP] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Chief Financial Officer (Last) (First) (Middle) C/O INSPIRE MEDICAL SYSTEMS, INC., 5500 WAYZATA BLVD., SUITE 1600 3. Date of Earliest Transaction (MM/DD/YY) 09/30/2019 (Street) GOLDEN VALLEY, MN55416 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 09/30/2019 M 15,000 D $ 2.07 17,706 D Common Stock 09/30/2019 M 9,200 D $ 0.94 26,906 D Common Stock 09/30/2019 M 3,800 D $ 0.94 30,706 D Common Stock 600 I By Daughter Common Stock 600 I By Son Common Stock 600 I By Son Common Stock 600 I By Son

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Stock Option (Right to Buy) $ 2.07 09/30/2019 M 15,000 ( 1 ) 05/31/2024 Common Stock 15,000 $ 0 37,706 D Stock Option (Right to Buy) $ 0.94 09/30/2019 M 9,200 ( 2 ) 03/31/2027 Common Stock 9,200 $ 0 6,589 D Stock Option (Right to Buy) $ 0.94 09/30/2019 M 3,800 ( 3 ) 12/31/2026 Common Stock 3,800 $ 0 2,215 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Buchholz Richard C/O INSPIRE MEDICAL SYSTEMS, INC. 5500 WAYZATA BLVD., SUITE 1600 GOLDEN VALLEY, MN55416 Chief Financial Officer Signatures /s/ Richard Buchholz 10/02/2019 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The option is fully vested and exercisable. ( 2 )The option, representing a right to purchase a total of 15,789 shares, vested and became exercisable as to 25% of the underlying shares on April 1, 2018, and the remaining 75% of the underlying shares have vested or will continue to vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. As of September 30, 2019, the option was vested and exercisable as to 9,539 of the underlying shares. ( 3 )The option, representing a right to purchase a total of 6,015 shares, vested and became exercisable as to 25% of the underlying shares on January 1, 2018 and the remaining 75% of the underlying shares have vested or will continue to vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. As of September 30, 2019, the option was vested and exercisable as to 4,009 of the underlying shares.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.